Search research articles
Contact Us
Filters
Showing results (1-10 of 25) with videos related to
Page
of 3
Sort By:
European Journal of Pharmacology
|
May 15, 2026
Nitric Oxide Signaling in Alzheimer's Disease: A Double-Edged Sword
Rufaida Wasim
Inflammopharmacology
|
August 27, 2025
Bioenergetic failure and oxidative stress: mitochondrial contributions to Alzheimer's disease
Rufaida Wasim
Inflammopharmacology
|
October 13, 2025
From infection to intervention: post-acute sequelae of SARS-CoV-2 infection and cardiovascular risk
Rufaida Wasim
Molecular Biology Reports
|
October 10, 2025
The gut immune axis in ulcerative colitis: insights from microbiome research
Rufaida Wasim
Inflammopharmacology
|
December 23, 2024
Across-the-board review on Omicron SARS-CoV-2 variant
Rufaida Wasim, Sumaiya, Asad Ahmad
Current Protein & Peptide Science
|
April 20, 2026
Targeting Drug-Resistant Tuberculosis with Antimicrobial Peptides: Opportunities and Challenges
Asad Ahmad, Rufaida Wasim, Anas Islam, et al.
Inflammopharmacology
|
January 6, 2026
NLRP3 inflammasome and Alzheimer's disease: bridging inflammation and neurodegeneration
Rufaida Wasim, Sumaiya Azmi, Asad Ahmad, et al.
Inflammopharmacology
|
April 11, 2026
HMGB1-mediated neuroinflammation: molecular mechanisms and emerging therapeutic approaches
Khalil Nuruddeen Ibrahim, Rufaida Wasim, Ebadur Rahman
Drug Research
|
June 2, 2025
Curcumin in Type 2 Diabetes Mellitus: A Natural Approach to Modulating Metabolic Dysfunction
Rufaida Wasim, Sumaiya Azmi, Mohammad Owais, et al.
Inflammopharmacology
|
April 12, 2025
Microbial imbalance in the gut: a new frontier in Rheumatoid arthritis research
Rufaida Wasim, Sumaiya, Asad Ahmad, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 25) with videos related to
Sort By:
Page
of 3
European Journal of Pharmacology
|
May 15, 2026
Nitric Oxide Signaling in Alzheimer's Disease: A Double-Edged Sword
Rufaida Wasim
Inflammopharmacology
|
August 27, 2025
Bioenergetic failure and oxidative stress: mitochondrial contributions to Alzheimer's disease
Rufaida Wasim
Inflammopharmacology
|
October 13, 2025
From infection to intervention: post-acute sequelae of SARS-CoV-2 infection and cardiovascular risk
Rufaida Wasim
Molecular Biology Reports
|
October 10, 2025
The gut immune axis in ulcerative colitis: insights from microbiome research
Rufaida Wasim
Inflammopharmacology
|
December 23, 2024
Across-the-board review on Omicron SARS-CoV-2 variant
Rufaida Wasim, Sumaiya, Asad Ahmad
Current Protein & Peptide Science
|
April 20, 2026
Targeting Drug-Resistant Tuberculosis with Antimicrobial Peptides: Opportunities and Challenges
Asad Ahmad, Rufaida Wasim, Anas Islam, et al.
Inflammopharmacology
|
January 6, 2026
NLRP3 inflammasome and Alzheimer's disease: bridging inflammation and neurodegeneration
Rufaida Wasim, Sumaiya Azmi, Asad Ahmad, et al.
Inflammopharmacology
|
April 11, 2026
HMGB1-mediated neuroinflammation: molecular mechanisms and emerging therapeutic approaches
Khalil Nuruddeen Ibrahim, Rufaida Wasim, Ebadur Rahman
Drug Research
|
June 2, 2025
Curcumin in Type 2 Diabetes Mellitus: A Natural Approach to Modulating Metabolic Dysfunction
Rufaida Wasim, Sumaiya Azmi, Mohammad Owais, et al.
Inflammopharmacology
|
April 12, 2025
Microbial imbalance in the gut: a new frontier in Rheumatoid arthritis research
Rufaida Wasim, Sumaiya, Asad Ahmad, et al.
Page
of 3